Nutritional monitoring becomes even more critical when combining surgical and pharmacological interventions
Eligibility depends on your medical history, current health, and clinical appropriateness
To illustrate, studies show that as much as two-thirds of the weight lost during GLP-1 therapy can be regained within a year of stopping the medication (Old et al., 2025)
Why microdosing is not the answer There are several reasons why microdosing is not effective: 1 Other than personal anecdotes, there is no strong evidence that microdosing leads to meaningful or lasting weight loss
The result is an immediate spike in blood glutathione levels, typically used in aesthetic settings
Sublingual tirzepatide is $289/mo month-to-monthnth across all commitment tiers, with HSA and FSA accounts accepted for tax-advantaged payment